WHO seeks additional clarification from Bharat Biotech, decision on November 3
By Administrator_ India Capital Sands The technical advisory group of the World Health Organisation on October 26 sought “additional clarifications” from Bharat Biotech to conduct a final “risk-benefit assessment” for Emergency Use Listing of its COVID-19 vaccine. The statement came hours after WHO official Dr. Margaret Harris had said that a recommendation was expected within the next 24 […]